WHO declares JN.1 a COVID "variant of interest." Here's what that means.
The JN.1 variant of COVID-19 is spreading, but health officials say the symptoms are not more severe and the added public health risk is "low."
Watch CBS News
The JN.1 variant of COVID-19 is spreading, but health officials say the symptoms are not more severe and the added public health risk is "low."
Two new reports show a clearer picture of just how many New Yorkers left the state during the pandemic.
The Health Department says flu cases surged 27% in New York state last week.
The Department of Health reported a 27% increase in cases across the state last week. CBS New York's Dick Brennan reports.
A highly-mutated descendant called JN.1 could be to blame.
The FDA has lengthened the shelf lives of some COVID-19 tests that still deliver accurate results past their printed expiration dates.
The next round of free COVID test orders will ship starting the week of Nov. 27.
The potential for a tripledemic has doctors reminding people there is still time to get vaccinated for all three.
The potential for a tripledemic has medical professional reminding people there is still time to get vaccinated for all three. CBS New York's Carolyn Gusoff reports.
According to a new Truth In Medicine poll, just 15% of people in the New York area have gotten it, while 39% plan to, 25% do not and 22% are undecided.
According to a new Truth In Medicine poll, just 15% of people in the New York area have gotten it, while 39% plan to, 25% do not and 22% are undecided. CBS New York's Jennifer McLogan reports.
As we head into cold weather season, city health officials are urging New Yorkers to get fully vaccinated against COVID, flu and RSV.
Researchers found that people with acute respiratory infections who tested negative for COVID-19 could still experience long-term symptoms including coughing, stomach pain and diarrhea.
Dr. Nidhi Kumar is On Call for CBS New York with how to figure out if it's COVID or if it's something else.
Americans still have ways to get vaccinated against COVID-19 at no out-of-pocket cost. Here's what to know.
The Biden administration is also pouring $600 million into more COVID tests manufacturing across the U.S.
The variant, which has an unusually large number of mutations, has also been spotted in numerous countries, but remains rare for now.
Vaccine experts considered narrower recommendations for only higher-risk groups, but decided almost all Americans could benefit.
Dr. Céline Gounder shares what you need to know about protecting yourself from COVID, RSV and the flu in the season ahead.
The new shots are similar to previously approved formulas but were updated to target strains of the virus descended from Omicron.
Many people may have questions about the new COVID-19 vaccine that's now available. Dr. Nidhi Kumar is On Call for CBS New York to answer some of those questions.
She's hoping to prevent a surge in cases during the fall and winter months and another "tripledemic."
A brand new COVID vaccine has been approved and is being distributed nationwide just in time for cooler months. CBS New York's Jessica Moore shows us how doctors and elected leaders are urging everyone to protect themselves and others. Read more: https://cbsloc.al/3LnhXpX
It comes as the FDA and CDC approved the latest COVID vaccine booster for the fall months.
The CDC recommends a new shot, targeting more a recent variant, for virtually all Americans to reduce the risk of severe illness, hospitalization or death.
